CCNA Phase II (2019-2024)

CCNA’s research in Phase II aimed to strengthen the understanding of:

  • How neurodegenerative diseases develop
  • Ways of slowing Dementia progression and eventually preventing it altogether
  • Dementia’s impact on the individual, families, and the community as a whole

CCNA’s research is organized into three Themes:

  • Theme 1: Prevention
    • Team 1 – Clinical Genetics and Gene Discovery/ Leads: Ekaterina Rogaeva and Ziv Gan-Or
    • Team 2 – Inflammation & Nerve Growth Factors / Leads: Claudio Cuello, Margaret Fahnestock, and Pedro Rosa-Neto
    • Team 3 – Protein Misfolding / Lead: Neil Cashman
    • Team 4 – Early Detection and Prevention of Neurodegenerative Diseases / Lead: Robert Bartha
    • Team 5 – Nutrition, Exercise, and Lifestyle in Alzheimer’s Disease Prevention / Lead: Guylaine Ferland
  • Theme 2: Treatment
    • Team 6 – Sleep and Dementia / Leads: Julie Carrier and Andrew Lim
    • Team 7 – Vascular Illness and its Impact on Neurodegenerative Diseases / Leads: Eric E. Smith and Bojana Stefanovic
    • Team 8 – Lewy Bodies, Aging, and Dementia / Lead: Richard Camicioli
    • Team 9 – Developing New Biomarkers / Leads: Roger A. Dixon and Pierre Bellec
    • Team 10 – Cognitive Intervention, Reserve and Brain Plasticity / Leads: Sylvie Belleville and Nicole Anderson
    • Team 11 – Prevention and Treatment of Neuropsychiatric Symptoms / Leads: Nathan Herrmann, Krista Lanctôt, and Dallas Seitz
    • Team 12 – Mobility, Exercise, and Cognition / Leads: Manuel Montero-Odasso and Louis Bherer
    • Team 13 – Frontotemporal Dementia / Leads: Elizabeth Finger and Simon Ducharme
  • Theme 3: Quality of Life
    • Team 14 – Multi-Morbidity and Dementia / Lead: Kenneth Rockwood
    • Team 15 – Issues in Dementia Care for Rural populations / Lead: Megan O’Connell
    • Team 16 – Driving & Dementia / Leads: Gary Naglie and Mark Rapoport
    • Team 17 – Interventions at the Sensory and Cognitive Interface / Leads: Natalie Phillips and Walter Wittich
    • Team 18 – Issues in Dementia Care for Indigenous Populations / Lead: Jennifer Walker
    • Team 19 – Integrating Dementia Patient Care into the Health Care System / Leads: Isabelle Vedel and Howard Bergman
  • Cross-Cutting Programs
    • Training and Capacity Building / Lead: Manuel Montero-Odasso
    • Women, Sex, Gender, and Dementia / Lead: Gillian Einstein
    • Knowledge Translation and Exchange / Leads: Carrie MacAiney and Howard Chertkow
    • Ethical, Legal and Social Implication / Leads: Julie Robillard and John Fisk
    • Engagement of People with Lived Experience of Dementia / Leads: Jennifer Bethell and Katherine McGilton
    • Indigenous Cognitive Health / Lead: Jennifer Walker and Pamela Roach
    • Stigma and Social Isolation Working Group / Leads: Sarah Fraser and Katherine McGilton

CCNA’s signature study, involving all three Themes, is The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND). It is a large scale clinical study aiming to understand dementia risk factors and tests of early detection of dementia. Interested participants may contact us here: ccna.RA@ladydavis.ca (Note that recruitment is temporarily paused)

Seven national platforms were established to facilitate the research.

This work builds on the research conducted at CCNA in Phase 1.

 

 

Go back to top